Chemoinformaics analysis of 2-(Chloromethyl)-2,3-dihydro-4(1H)-quinolinone
| Molecular Weight | 195.649 | nRot | 1 |
| Heavy Atom Molecular Weight | 185.569 | nRig | 12 |
| Exact Molecular Weight | 195.045 | nRing | 2 |
| Solubility: LogS | -3.644 | nHRing | 1 |
| Solubility: LogP | 2.56 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 27.4499 |
| nHD | 1 | BPOL | 11.9801 |
| QED | 0.697 |
| Synth | 3.018 |
| Natural Product Likeliness | 0.226 |
| NR-PPAR-gamma | 0.067 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.811 |
| MDCK | 0.0000734 |
| BBB | 0.988 |
| PPB | 0.587317 |
| VDSS | 1.078 |
| FU | 0.365344 |
| CYP1A2-inh | 0.903 |
| CYP1A2-sub | 0.875 |
| CYP2c19-inh | 0.723 |
| CYP2c19-sub | 0.24 |
| CYP2c9-inh | 0.356 |
| CYP2c9-sub | 0.443 |
| CYP2d6-inh | 0.236 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.346 |
| CYP3a4-sub | 0.179 |
| CL | 6.429 |
| T12 | 0.647 |
| hERG | 0.041 |
| Ames | 0.909 |
| ROA | 0.651 |
| SkinSen | 0.291 |
| Carcinogencity | 0.843 |
| EI | 0.367 |
| Respiratory | 0.843 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.872285 |